If the peptide you mean is one that increases growth hormone/GH signaling—such as GHRP-6, GHRP-2, ipamorelin, or MK-677/ibutamoren—then glucose and insulin sensitivity are legitimate concerns. The FDA notes that some of these substances can increase blood glucose by reducing insulin sensitivity...